Complete Remission of Acute Myeloid Leukemia in Induction and Consolidation Chemotherapy without Bone Marrow Transplantation: Lessons Learned from Good Presentation Case
Acute myeloid leukemia (AML) is a clinically morphologically and genetically heterogeneous disease with variable responses to therapy. The majority of the patients eventually relapse and succumb to the disease. Therapeutic modalities of induction chemotherapy, consolidation, and bone marrow transpla...
Main Authors: | Tuti Sri Hastuti, Rachmat Sumantri, Indra Wijaya |
---|---|
Format: | Article |
Language: | English |
Published: |
Universitas Padjajaran
2019-03-01
|
Series: | Majalah Kedokteran Bandung |
Subjects: | |
Online Access: | http://journal.fk.unpad.ac.id/index.php/mkb/article/view/1634 |
Similar Items
-
OUTCOME OF CHEMOTHERAPY IN NON ACUTE PROMYELOCYTIC ACUTE MYELOID LEUKAEMIA
by: Nighat Shahbaz, et al.
Published: (2020-10-01) -
A favorable inductive remission rate for decitabine combined with chemotherapy as a first course in <60‐year‐old acute myeloid leukemia patients with myelodysplasia syndrome features
by: Fengqi Liu, et al.
Published: (2019-09-01) -
Serum levels of soluble adhesion molecules in newly diagnosed acute myeloid leukemia and in complete remission suggest endothelial cell activation by myeloblasts
by: Tomas Kupsa, et al.
Published: (2017-03-01) -
Efficacy of autologous versus allogeneic peripheral blood hematopoietic stem cell transplantation in non-high-risk acute myeloid leukemia patients in first complete remission
by: XIAO Han, et al.
Published: (2020-09-01) -
The outcome of Autologous Stem Cell Transplantation in First Complete Remission Acute Myeloid Leukemia Patients- Single Center Study
by: Arash Jalali, et al.
Published: (2011-10-01)